The latest news & events
Keep up to date with company updates, industry news, investor
press releases and event information.
![](https://kneat.com/wp-content/uploads/2020/01/1365x720newsfeatureimage-370x195.png)
January 06, 2020 | Kneat Launches Training Arm “Kneat Academy”
LIMERICK, Ireland January 06, 2020 – Kneat is pleased to announce the launch of its newly established training arm, Kneat…
Read More![](https://kneat.com/wp-content/uploads/2020/01/Durham-560x640-323x370.png)
Kneat joins 2020 ISPE CASA Life Sciences Technology Conference
2020 ISPE CASA Life Sciences Technology Conference, March 10, Durham, USA The 2020 ISPE CASA Life Sciences Technology Conference, March…
Read More![](https://kneat.com/wp-content/uploads/2020/01/San-Francisco-560x640-324x370.png)
Kneat to exhibit at 2020 ISPE Facilities of the Future
Facilities of the Future 2020, Jan. 30-31, San Francisco, USA The 2020 ISPE Facilities of the Future, January 30 –…
Read More![](/wp-content/themes/kneat/assets/img/investor-news-thumbnail.jpg)
Kneat Signs Global Biopharma Leader
LIMERICK, Ireland December 11, 2019 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that it has signed a five-year master service agreement with another of the world’s leading biopharmaceutical companies. This US headquartered company has over 10,000 employees and operations
Read More![](/wp-content/themes/kneat/assets/img/investor-news-thumbnail.jpg)
Kneat Reports Third Quarter Results
LIMERICK, Ireland, November 26, 2019 /CNW/ – kneat.com, inc. (TSXV: KSI) (“Kneat”) today announced its financial results for the quarter ended September 30, 2019. All dollar amounts are presented in Canadian dollars unless otherwise stated. Third Quarter Highlights Revenue of $1,586,033 was
Read More![](/wp-content/themes/kneat/assets/img/investor-news-thumbnail.jpg)
Big Pharma selects Kneat’s SaaS Platform for Digitalization of its Validation Work Processes
LIMERICK, Ireland November 25, 2019 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that it has signed a five-year master service agreement with another one of the worlds largest pharmaceutical companies, to digitalize key validation processes across its manufacturing sites.
Read More![](https://kneat.com/wp-content/uploads/2019/11/Los-Angeles-640x560-370x370.png)
Kneat Sponsors ISPE Greater Los Angeles Chapter Conference
Data Integrity ISPE LA 2019, December 05, Los Angeles, USA Data Integrity ISPE LA 2019, takes place on December 5th…
Read More![](https://kneat.com/wp-content/uploads/2019/11/Frankfurt-640x560-370x324.png)
Kneat to exhibit at ManuPharma 2019
ManuPharma 2019, December 03-04, Frankfurt ManuPharma 2019, takes place on December 3rd – 4th in Frankfurt, Germany ManuPharma is firmly…
Read More![](/wp-content/themes/kneat/assets/img/investor-news-thumbnail.jpg)
Kneat Appoints New Chief Financial Officer
LIMERICK, Ireland September 20, 2019 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat or the company”) today announced that it has appointed Mr. Hugh Kavanagh as its Chief Financial Officer effective September 23, 2019 following the resignation of Ms. Sarah Oliver who will assist in the transition. Mr.
Read More![](/wp-content/themes/kneat/assets/img/investor-news-thumbnail.jpg)
Big Pharma selects Kneat’s Commissioning, Qualification and Validation platform
LIMERICK, Ireland September 17, 2019 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that it signed a three-year contract with one of the worlds largest pharmaceutical companies to enable digital transformation for its many validation work processes.
Read More![](/wp-content/themes/kneat/assets/img/investor-news-thumbnail.jpg)
Kneat Reports Second Quarter Results
LIMERICK, Ireland, Aug. 27, 2019 /CNW/ – kneat.com, inc. (TSXV: KSI) (“Kneat”) today announced its financial results for the quarter ended June 30, 2019. All dollar amounts are presented in Canadian dollars unless otherwise stated. Second Quarter Highlights Revenue of $528,812 was recognized
Read More![](https://kneat.com/wp-content/uploads/2019/08/FDA-office-1365x720-370x195.png)
August 20, 2019 | FDA to Close Public Consultation on ICH M10 Bioanalytical Method Validation
The US Food and Drug Administration (FDA) public consultation of the International Council for Harmonisation (ICH) draft guideline, M10 Bioanalytical…
Read MoreContact
Talk to us
Find out how Kneat can make your validation easier, faster, and smarter.
Start your paperless validation revolution by speaking to our experts.